TW200500336A - Chlorogenic acid, isochlorogenic acid composition, and pharmacology use thereof - Google Patents

Chlorogenic acid, isochlorogenic acid composition, and pharmacology use thereof

Info

Publication number
TW200500336A
TW200500336A TW092116577A TW92116577A TW200500336A TW 200500336 A TW200500336 A TW 200500336A TW 092116577 A TW092116577 A TW 092116577A TW 92116577 A TW92116577 A TW 92116577A TW 200500336 A TW200500336 A TW 200500336A
Authority
TW
Taiwan
Prior art keywords
acid
isochlorogenic
chlorogenic acid
composition
compositions
Prior art date
Application number
TW092116577A
Other languages
Chinese (zh)
Other versions
TWI248431B (en
Inventor
Kung-Ming Lu
Jian-Pin Zuo
Original Assignee
Microbio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbio Co Ltd filed Critical Microbio Co Ltd
Priority to TW92116577A priority Critical patent/TWI248431B/en
Publication of TW200500336A publication Critical patent/TW200500336A/en
Application granted granted Critical
Publication of TWI248431B publication Critical patent/TWI248431B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention disclosed a composition containing chlorogenic acid and isochlorogenic acid extracted from natural plant. Medical tests indicated that the invented composition has conspicuous anti-SARS-viral activities. Chlorogenic acid and isochlorogenic acid with activie and Vitamin C are used as main active ingredients, added with adjuvant, and an auxiliary agent or carrier to prepare different types of compositions. The invented compositions can be applied in the treatment and prevention of diseases caused by SARS virus.
TW92116577A 2003-06-18 2003-06-18 Chlorogenic acid, isochlorogenic acid composition, and pharmacology use thereof TWI248431B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW92116577A TWI248431B (en) 2003-06-18 2003-06-18 Chlorogenic acid, isochlorogenic acid composition, and pharmacology use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW92116577A TWI248431B (en) 2003-06-18 2003-06-18 Chlorogenic acid, isochlorogenic acid composition, and pharmacology use thereof

Publications (2)

Publication Number Publication Date
TW200500336A true TW200500336A (en) 2005-01-01
TWI248431B TWI248431B (en) 2006-02-01

Family

ID=37429117

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92116577A TWI248431B (en) 2003-06-18 2003-06-18 Chlorogenic acid, isochlorogenic acid composition, and pharmacology use thereof

Country Status (1)

Country Link
TW (1) TWI248431B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5656350B2 (en) * 2008-10-08 2015-01-21 ポッカサッポロフード＆ビバレッジ株式会社 Anti-SARS coronavirus agent and method for promoting anti-SARS coronavirus action

Also Published As

Publication number Publication date
TWI248431B (en) 2006-02-01

Similar Documents

Publication Publication Date Title
MY143795A (en) Tetrahydropyridoindole derivatives
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
MX2010003258A (en) Use of a novel natural agent in cosmetic compositions.
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
BRPI1007379B8 (en) pharmaceutical compositions for the treatment or prevention of oral infections by e. coli
MX2009013810A (en) Use of homo- and copolymers for stabilizing active ingredient formulations.
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
PL375621A1 (en) Pharmaceutical compositions comprising flavonoids and menthol
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
TW200514772A (en) Novel tetrahydropyridine derivatives
ATE409065T1 (en) INHIBITORS OF 17 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
PL1962815T3 (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
TW200630343A (en) 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
TW200621773A (en) Bicyclononene derivatives
MX2009002224A (en) Xanthoxyline-based composition and cosmetic use thereof.
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
TW200628468A (en) Bicyclononene derivatives
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
MX2007000120A (en) Herbal composition.
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees